Genes characterizing the immune heterogeneity of RA are associated with AML, and KLRBA may be a potential target for AML treatment.
Keyphrases
- acute myeloid leukemia
- rheumatoid arthritis
- allogeneic hematopoietic stem cell transplantation
- genome wide
- single cell
- disease activity
- bioinformatics analysis
- genome wide identification
- ankylosing spondylitis
- interstitial lung disease
- combination therapy
- transcription factor
- systemic sclerosis
- idiopathic pulmonary fibrosis
- risk assessment